🇺🇸 FDA
Pipeline program

Oral Zonisamide Therapy

2024-K171-02

Approved small_molecule active

Quick answer

Oral Zonisamide Therapy for Epilepsies, Partial is a Approved program (small_molecule) at Affiliated Hospital of Nantong University with 1 ClinicalTrials.gov record(s).

Program details

Company
Affiliated Hospital of Nantong University
Indication
Epilepsies, Partial
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials